MALT Lymphoma: Potential for Transformation to Diffuse Large B-Cell Lymphoma (DLBCL)
MALT lymphoma (extranodal marginal zone B-cell lymphoma) arises from mucosa-associated lymphoid tissue (stomach most common, also lung, salivary gland, thyroid, orbit, skin). It is indolent but can transform to diffuse large B-cell lymphoma (DLBCL), an aggressive subtype.
Transformation risk factors:
- Genomic complexity (e.g., TP53 mutation, MYC rearrangement)
- Advanced stage at diagnosis
- Specific sites (e.g., non-gastric)
- Persistence/progression after H. pylori eradication (gastric MALT)
Transformation typically occurs years after diagnosis but can be earlier. Surveillance with regular imaging, endoscopy (if gastric), and clinical assessment is crucial. Transformed DLBCL requires aggressive chemoimmunotherapy (R-CHOP).
Lymphoma - Related Articles
- Understanding Lymph Node Cancer (Lymphoma): Causes, Risk Factors & Symptoms
- Sentinel Lymph Node Biopsy: Understanding the Procedure & Benefits
- Periventricular Leukomalacia (PVL) Diagnosis: Process and Tests
- Lymph Node Hilum: Vascular & Lymphatic Gateway
- Stoma Color Changes: What Pale or Pink May Indicate
- Understanding Lymphoma: Types, Symptoms & Treatment Options
- B-Cell Lymphoma Symptoms: What to Watch For
